Experiment: 2N9B

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
2	3D HCACO	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
3	3D HNCO	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
4	3D HN(CO)CA	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
5	3D HNCA	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
6	3D CBCA(CO)NH	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
7	3D CBCANH	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
8	2D HBCBCGCDHD	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
9	3D H(CCO)NH	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
10	3D HCCH-TOCSY	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
11	3D HCCH-COSY	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
12	2D 1H-13C HSQC aliphatic	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
13	2D 1H-13C HSQC	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
14	2D 1H-15N HSQC NH2 only	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
15	3D 1H-15N NOESY	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308
16	3D 1H-13C NOESY	1.1 mM [U-100% 13C; U-100% 15N] entity-1, 100 mM potassium phosphate-2, 1 mM EDTA-3, 0.03 % sodium azide-4	90% H2O/10% D2O	0.6	6.5	ambient	308

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	850
2	Varian	INOVA	600

NMR Refinement
Method	Details	Software
simulated annealing		Xplor-NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	Xplor-NIH	2.38	Schwieters, Kuszewski, Tjandra and Clore
2	refinement	Xplor-NIH	2.38	Schwieters, Kuszewski, Tjandra and Clore
3	chemical shift assignment	CCPN	2.4.1	CCPN
4	data analysis	CCPN	2.4.1	CCPN
5	peak picking	CCPN	2.4.1	CCPN
6	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.